Considerations when prescribing trimethoprim-sulfamethoxazole
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 8, 2011
has subject area
- 11 Medical and Health Sciences (FoR)
- Abnormalities, Drug-Induced (MeSH)
- Anti-Infective Agents (MeSH)
- Anticoagulants (MeSH)
- Biomedical Research (MeSH)
- Cytochrome P-450 Enzyme System (MeSH)
- Drug Eruptions (MeSH)
- Drug Interactions (MeSH)
- Female (MeSH)
- Folic Acid Deficiency (MeSH)
- General & Internal Medicine (Science Metrix)
- Hematologic Diseases (MeSH)
- Hemolysis (MeSH)
- Humans (MeSH)
- Hyperkalemia (MeSH)
- Hypoglycemia (MeSH)
- Hypoglycemic Agents (MeSH)
- Immunocompromised Host (MeSH)
- Infant, Newborn (MeSH)
- Infant, Small for Gestational Age (MeSH)
- Kidney (MeSH)
- Nervous System Diseases (MeSH)
- Pregnancy (MeSH)
- Trimethoprim, Sulfamethoxazole Drug Combination (MeSH)
- Warfarin (MeSH)